SCYL1 and breast carcinoma: In an effort to identify mTORC1 effector proteins, responding to its inactivation by dynamic changes in their phosphorylation status, we previously performed a quantitative phosphoproteomic screen in epithelial MCF-7 breast cancer cells and identified SCYL1 as a strong candidate23.